Cuban Researchers Develop Potential Lung Cancer Vaccine
Roswell Park Cancer Institute, in a partnership with Cuban researchers, has FDA approval for a phase I clinical study of CIMAvax, a new vaccine for lung cancer. This is an historic first in the modern era for such a partnership between Cuba and an American institution. In 2015, Gov. Cuomo brought a trade mission to …